GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Grant Of Patent
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform that the Company has been granted patent for an invention entitled "A FREEZE DRIED PARENTERAL COMPOSITION OF OMADACYCLINE TOSYLATE AND PROCESS FOR PREPARATION THEREOF" on September 14, 2023 for the term of 20 years effective from April 19, 2021 in accordance with the provisions of the Patents Act, 1970.
Gufic Biosciences gains on Aussie, Brazilian nod to pain-killer drug
"The medicine will be used for short-term treatment of acute pain and post-operative pain in adult patients, the company said in a regulatory filing at the exchanges. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith a press release being issued by the Company on approval of TGA, Australia and ANVISA, Brazil for Parecoxib 40mg injection, the contents of which is self-explanatory. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors/ Analysts (Participants) as per the details attached herewith. The schedule of the aforementioned meeting is subject to change and the change may occur due to exigencies on the part of Participants / Company. We hereby confirm that the discussion during the meeting will be based on already published information and no Unpublished Price Sensitive Information is proposed to be discussed in this meeting. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find attached herewith the copies of Newspaper published today in Business Standard (All edition in English language) and Mumbai Lakshadeep (Mumbai edition in Marathi language) which includes the following: 1. Intimation of 39th AGM of our Company to be held on Friday, September 29, 2023 at 3.30 p.m. through VC/ OAVM. 2. Completion of email dissemination on Wednesday, September 6, 2023 of the Notice of 39th AGM and Annual Report for FY 2022-23 to the members whose email ids are registered with the Company/Depositories. 3. Details of remote e-voting facility provided to the shareholders of the Company to enable them to cast their votes on the resolutions proposed to be passed at the AGM. GUFIC BIOSCIENCES LTD. - 509079 - Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are attaching herewith the Business Responsibility & Sustainability Report of the Company for the Financial Year 2022-23. GUFIC BIOSCIENCES LTD. - 509079 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report for the Financial Year 2022-23 along with Notice of the AGM. GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Record Date For Final Dividend & 39Th Annual General Meeting
Intimation of book closure and record date for the purpose of 39th Annual General Meeting and payment of final dividend for the financial year ended March 31, 2023 is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Shareholders Meeting - 39Th Annual General Meeting Of The Company Scheduled To Be Held On Friday, September 29, 2023
With reference to the above captioned matter, we wish to inform you that the 39th Annual General Meeting ("AGM") of the Company is scheduled to be held on Friday, September 29, 2023 at 3:30 p.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) to transact the Ordinary and Special Business as set out in the Notice convening the 39th AGM dated September 01, 2023. A copy of the Notice is attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors/ Analysts (Participants) as per the details attached herewith.